The beneficial impacts of SGLT2 inhibitors on HCC may include regulating metabolic reprograming, blocking glucose uptake by cancer cells, promoting weight loss, reducing inflammation or decreasing oxidative stress [25, 26, 31, 32]. This evidence concerns the gene SLC5A2 and cancer.